Most people don’t know they have hypertension, and a new recommendation advises that pregnant women should be screened for blood pressure disorders at every appointment; patients in primary care face long wait times, which may be due to physician incentives under value-based payments; a lawsuit in New Jersey targets the residency requirement to allow aid in dying for those out of state.
Pregnant women should be screened for hypertensive disorders at each prenatal appointment, new guidelines suggest, as medical experts encourage action against growing threats to maternal health, according to The Wall Street Journal. This recommendation was made Tuesday by the US Preventive Services Task Force and broadens the 2017 guidance that said to regularly screen only for preeclampsia. Additionally, an estimated 1 in 3 adults globally live with hypertension, but most don’t receive adequate treatment because they don’t know they have it, according to a World Health Organization statement, reported The Washington Post. According to the statement, if just 50% of those with high blood pressure had control over the condition, 76 million deaths would be avoided by 2050.
In an opinion piece published by STAT News, an internist and clinical assistant professor highlighted that trouble in scheduling an urgent or time-sensitive appointment is now the most common complaint of patients in a primary care practice. This is not the exception, but the rule, the piece noted, and a 2022 countrywide survey showed that it takes an average of 20.6 days to get a family medicine appointment. The understaffed clinician workforce is just 1 reason for this trend, the author wrote; additionally, value-based payment has changed physician incentives in primary care practices other than concierge medicine.
Since 2019, aid in dying has been legal in New Jersey, but laws restrict assisting terminally ill residents to only those from the state, prompting a patient to take New Jersey officials to federal court to file a lawsuit to expand services, according to The New York Times. The lawsuit was filed in August and argues that New Jersey’s residency requirement violates the Constitutional privileges and immunities and equal protection clauses. The suit also says that prohibiting New Jersey doctors to assist in aid-in-dying care to out-of-state patients limits interstate commerce, the province of Congress. The New Jersey Attorney General’s office declined the opportunity to comment to the Times.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Poor Sleep Quality Associated With Pulmonary Arterial Hypertension
November 14th 2024Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep quality, and dyspnea was a significant predictor of sleep quality, independent of disease severity, according to this study.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Refinements to European Strategy Can Improve PAH-CHD Stratification
November 6th 2024When patients were re-classified based on the adjusted thresholds of N-terminal pro-brain natriuretic peptide and 6-minute walk distance and the inclusion of TAPSE rather than right atria area, classification of patients improved significantly.
Read More